02297.HK
Rainmed Medical Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 0.17
+7.84%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 46.8M | 19.2M | 39.8M | 73.2M | 83.6M |
| Cost of Revenue | 29.4M | 10.1M | 16.0M | 24.7M | 13.8M |
| Gross Profit | 17.4M | 9.0M | 23.9M | 48.6M | 69.8M |
| Operating Expenses | |||||
| R&D Expense | 45.9M | 24.3M | 35.4M | 41.3M | 44.2M |
| SG&A Expense | 144.1M | 71.1M | 97.8M | 90.8M | 108.1M |
| General & Admin Expense | 83.4M | 42.9M | 47.0M | 19.9M | 41.3M |
| Selling & Marketing Expense | 60.8M | 28.2M | 50.8M | 70.9M | 66.8M |
| Other Expenses | 4.1M | (7.2M) | 8.9M | 44.6M | 60.8M |
| Total Operating Expenses | 194.1M | 88.3M | 142.2M | 176.7M | 213.1M |
| Cost and Expenses | 223.5M | 98.4M | 158.1M | 201.4M | 226.9M |
| Operating Income (EBIT) | (176.6M) | (79.2M) | (118.3M) | (128.2M) | (143.3M) |
| Non-Operating | |||||
| Interest Income | 2.0M | 500.0K | 3.9M | 12.4M | 3.5M |
| Interest Expense | 4.0M | 720.0K | 936.0K | 1.3M | 760.0K |
| Net Interest Income | (3.8M) | (220.0K) | (936.0K) | 11.1M | 2.7M |
| Other Non-Op Income/Expense | 1.3M | (220.0K) | 3.0M | 11.1M | (1.2B) |
| Non-Operating Income (excl Interest) | (34.3M) | (4.4M) | (18.8M) | (12.4M) | 1.2B |
| EBT (Pre-Tax Income) | (175.3M) | (79.4M) | (115.3M) | (117.1M) | (1.4B) |
| Income Tax Expense | (169.0K) | (37.0K) | 242.0K | (22.0K) | (5.5M) |
| Bottom Line | |||||
| Net Income | (170.9M) | (77.1M) | (113.5M) | (115.8M) | (1.3B) |
| Earnings from Cont. Ops | (175.3M) | (79.4M) | (115.5M) | (117.1M) | (1.3B) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (170.9M) | (77.1M) | (113.5M) | (115.8M) | (1.3B) |
| Per Share | |||||
| Basic EPS | (HK$0.14) | (HK$0.06) | (HK$0.10) | (HK$0.10) | (HK$1.50) |
| Diluted EPS | (HK$0.14) | (HK$0.06) | (HK$0.10) | (HK$0.10) | (HK$1.50) |
| Revenue Per Share | HK$0.04 | HK$0.01 | HK$0.04 | HK$0.06 | HK$0.09 |
| Shares | |||||
| Basic Shares Outstanding | 1.3B | 1.3B | 1.1B | 1.2B | 898.2M |
| Diluted Shares Outstanding | 1.3B | 1.3B | 1.1B | 1.2B | 898.2M |
| Profitability Metrics | |||||
| EBITDA | (112.5M) | (67.4M) | (83.0M) | (93.5M) | (1.3B) |
| D&A | 29.8M | 7.5M | 16.6M | 22.2M | 16.7M |
| EBIT | (142.4M) | (74.9M) | (99.5M) | (115.8M) | (1.4B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026